Insights

Innovative Therapeutics The Gene Therapy Program at the University of Pennsylvania is focused on developing next-generation gene transfer vectors and transformative genetic therapeutics, presenting opportunities for partnerships in advanced biotech tools, delivery systems, and commercial-scale manufacturing solutions.

Research & Development Focus With extensive publication history and over 110 patents, the program demonstrates a strong pipeline of cutting-edge gene therapy technologies, indicating a demand for specialized research tools, licensing, and collaborative R&D support services.

Funding Opportunities Although specific funding figures are not disclosed, the company's revenue range of $25M to $50M and diverse funding base highlight potential areas for financial tools, grant management, and funding optimization solutions tailored to biotech research institutions.

Security & Data Management Recent news about cybersecurity and data breaches at the university underscores a critical need for advanced security solutions, data protection services, and compliance tools, creating opportunities to address security vulnerabilities in highly sensitive academic research environments.

Gene Therapy Program | University of Pennsylvania Tech Stack

Gene Therapy Program | University of Pennsylvania uses 8 technology products and services including Varnish, Modernizr, jQuery, and more. Explore Gene Therapy Program | University of Pennsylvania's tech stack below.

Varnish

Caching

Modernizr

Javascript Libraries

jQuery

Javascript Libraries

Slick

Javascript Libraries

Slider Revolution

Miscellaneous

HSTS

Security

Facebook

Widgets

Email Encoder for Wordpress

Widgets

Gene Therapy Program \| University of Pennsylvania Email Formats	Example	Percentage
FLast@upenn.edu	JDoe@upenn.edu	83%
FirstL@upenn.edu	JohnD@upenn.edu	7%
Last@upenn.edu	Doe@upenn.edu	5%
LastF@upenn.edu	DoeJ@upenn.edu	5%

Gene Therapy Program | University of Pennsylvania Email Formats

Example

Percentage

FLast@upenn.edu

JDoe@upenn.edu

83%

FirstL@upenn.edu

JohnD@upenn.edu

Last@upenn.edu

Doe@upenn.edu

LastF@upenn.edu

DoeJ@upenn.edu

Frequently Asked Questions

What is Gene Therapy Program | University of Pennsylvania's phone number?

You can contact Gene Therapy Program | University of Pennsylvania's main corporate office by phone at

+1-215-573-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Gene Therapy Program | University of Pennsylvania's stock symbol?

Gene Therapy Program | University of Pennsylvania is a publicly traded company; the company's stock symbol is N/A.

What is Gene Therapy Program | University of Pennsylvania's official website and social media links?

Gene Therapy Program | University of Pennsylvania's official website is upenn.edu and has social profiles on LinkedIn.

What is Gene Therapy Program | University of Pennsylvania's SIC code NAICS code?

Gene Therapy Program | University of Pennsylvania's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Gene Therapy Program | University of Pennsylvania have currently?

As of December 2025, Gene Therapy Program | University of Pennsylvania has approximately 201 employees across 2 continents, including North AmericaEurope. Key team members include Chief Medical Officer: F. C.Director: S. G.Associate Director, Large Animal Rescourcing: S. C.. Explore Gene Therapy Program | University of Pennsylvania's employee directory with LeadIQ.

What industry does Gene Therapy Program | University of Pennsylvania belong to?

Gene Therapy Program | University of Pennsylvania operates in the Biotechnology Research industry.

What technology does Gene Therapy Program | University of Pennsylvania use?

Gene Therapy Program | University of Pennsylvania's tech stack includes VarnishModernizrjQuerySlickSlider RevolutionHSTSFacebookEmail Encoder for Wordpress.

What is Gene Therapy Program | University of Pennsylvania's email format?

Gene Therapy Program | University of Pennsylvania's email format typically follows the pattern of FLast@upenn.edu. Find more Gene Therapy Program | University of Pennsylvania email formats with LeadIQ.

When was Gene Therapy Program | University of Pennsylvania founded?

Gene Therapy Program | University of Pennsylvania was founded in 1993.

Gene Therapy Program | University of Pennsylvania

Biotechnology ResearchPennsylvania, United States201-500 Employees

Dedicated to discovery + translational research and led by Dr. James Wilson, the Gene Therapy Program (GTP) at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. 

Dr. Wilson's commitment to patients with rare diseases stems from his days as a graduate student and medical student at the University of Michigan between 1977 and 1984. He was discouraged by the lack of available treatments for rare disease patients, but optimistic that science could yield solutions with his initial focus being gene therapy. He completed his training in Internal Medicine at the Massachusetts General Hospital followed by a postdoctoral fellowship at the Whitehead Institute where he began his work in gene therapy.

After launching his faculty career in the Howard Hughes Medical Institute and the University of Michigan, he moved to the University of Pennsylvania in 1993. Jim’s laboratory has made seminal contributions to the technology of gene transfer and has paved the way for translation of these technologies into the clinic. He has published more than 550 papers and is named on more than 110 patents.

Today, the goals of the Gene Therapy Program are to develop and commercialize transformative, genetic-based therapeutics. These goals are driven by the unmet needs of patients with inherited genetic diseases.

The Gene Therapy Program currently employs more than 350+ full-time employees with an annual operating budget based on funding from a diverse group of public and private sponsors.

Insights

Similar companies to Gene Therapy Program | University of Pennsylvania

Orchard Therapeutics

AVROBIO

GenSight Biologics

Editas Medicine

uniQure

bluebird bio

Oxford Biomedica